Mendota Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9
Closed -$66 78
2025
Q4
$66 Hold
9
﹤0.01% 100
2025
Q3
$98 Hold
9
﹤0.01% 114
2025
Q2
$89 Hold
9
﹤0.01% 97
2025
Q1
$136 Hold
9
﹤0.01% 114
2024
Q4
$136 Sell
9
-20
-69% -$326 ﹤0.01% 364
2024
Q3
$557 Buy
29
+20
+222% +$415 ﹤0.01% 380
2024
Q2
$189 Sell
9
-5
-36% -$99 ﹤0.01% 365
2024
Q1
$266 Hold
14
﹤0.01% 318
2023
Q4
$202 Hold
14
﹤0.01% 366
2023
Q3
$240 Hold
14
﹤0.01% 288
2023
Q2
$285 Buy
14
+1
+8% +$22 ﹤0.01% 287
2023
Q1
$462 Hold
13
﹤0.01% 292
2022
Q4
$375 Buy
+13
New +$332 ﹤0.01% 291

Other funds holding OGN

Mendota Financial Group's OGN Position: Q1 2026 in Review

Mendota Financial Group sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 9 shares — an estimated $66 sold.

Mendota Financial Group first reported a position in OGN in Q4 2022 and held it in 13 quarters. The position peaked at $557 in Q3 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Mendota Financial Group reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Mendota Financial Group sold 9 Organon & Co shares in Q1 2026, an estimated $66.
  • Mendota Financial Group first reported a position in Organon & Co in Q4 2022 and held it in 13 quarters.
  • Mendota Financial Group's Organon & Co position peaked at $557 in Q3 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Mendota Financial Group's 13F filing for Q1 2026, filed 16 Apr 2026.